Cost-Effectiveness of Striant Testosterone Buccal System Across Socioeconomic Groups
Reading Time: 2 minutes Introduction The Striant testosterone buccal system offers a unique approach to testosterone replacement therapy (TRT) for American males experiencing hypogonadism. As healthcare costs continue to escalate, understanding the cost-effectiveness of such treatments across different socioeconomic groups is crucial. This article delves into a comprehensive cost-effectiveness analysis of the Striant system, examining its outcomes and expenses to provide a clearer picture of its value proposition for patients from varying economic backgrounds. Overview of Striant Testosterone Buccal System The Striant system is a buccal tablet designed to deliver testosterone directly through the buccal mucosa, offering a non-invasive alternative to injections or gels....


